お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、糞便移植治療の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に糞便移植治療市場を分類しています。
本レポートでは世界の糞便移植治療市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Enterome、Ferring Pharmaceuticals、Finch Therapeutics Group、MaaT Pharma、Seres Therapeutics、OpenBiome、Qualigen Therapeutics、Vedanta Biosciences

レポートは糞便移植治療の主要生産者を調査し、主要地域や国の消費状況も提供します。糞便移植治療の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Transcolonoscopic Transplantation
    Nasoenteric Tube Perfusion
    Oral Capsule

用途別の市場セグメント：
    Clostridium Difficile Infection (CDI)
    Inflammatory Bowel Disease (IBD)
    Irritable Bowel Syndrome (IBS)
    Metabolic Syndrome
    Neurological Diseases
    Others

本レポートの詳細内容
本レポートは、世界の糞便移植治療市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて糞便移植治療市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の糞便移植治療生産量、成長率、市場シェアを調査している。

二. 消費面では、糞便移植治療の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの糞便移植治療売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の糞便移植治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本糞便移植治療のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：糞便移植治療のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 糞便移植治療の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける糞便移植治療の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章糞便移植治療メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：糞便移植治療の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：糞便移植治療の主要メーカーの概要を提供し、製品の説明と仕様、糞便移植治療の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：糞便移植治療の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Fecal Transplant Treatment market is projected to grow from US$ 1217 million in 2025 to US$ 1627 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
Fecal transplant treatment is a therapy that transplants functional flora from the feces of healthy donors into the patient's intestines to rebuild the balance of intestinal microorganisms and treat intestinal and extraintestinal diseases. Its core principle is to use healthy flora to inhibit pathogenic microorganisms, repair intestinal barrier function and regulate the immune system, and improve the pathological state caused by flora imbalance through flora transplantation. Fecal transplant treatment is suitable for exploratory treatment of Clostridium difficile infection (CDI), inflammatory bowel disease (IBD) (ulcerative colitis, Crohn's disease), irritable bowel syndrome (IBS), metabolic syndrome (obesity, diabetes), neurological diseases (autism, Parkinson's disease), etc.
From the perspective of the global market, fecal transplant treatment continues to develop. North America dominates the market, and companies such as OpenBiome and Finch Therapeutics are promoting commercialization. The European Union classifies FMT as an "advanced therapeutic medicinal product (ATMP)" and requires standardized production. The United Kingdom and the Netherlands are leading in clinical trials and flora construction. In the Asia-Pacific region, the research progress in China and India is accelerating, but it will take a long time to achieve commercialization. The intensification of antibiotic resistance, breakthroughs in microbiome research, and the continuous improvement of regulatory policies are all driving the continuous development of fecal transplantation therapy. Manufacturers' competition focuses on standardized production and expanded indications. However, safety disputes, regulatory complexity, and patient acceptance all limit the rapid development of fecal transplantation therapy. In general, fecal microbial transplantation is a milestone in microbiome medicine, and its commercialization potential is closely related to the depth of intestinal flora research and the maturity of the regulatory framework.
In terms of production side, this report researches the Fecal Transplant Treatment production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Fecal Transplant Treatment by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Fecal Transplant Treatment, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Fecal Transplant Treatment, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Fecal Transplant Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fecal Transplant Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Fecal Transplant Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Fecal Transplant Treatment sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Enterome, Ferring Pharmaceuticals, Finch Therapeutics Group, MaaT Pharma, Seres Therapeutics, OpenBiome, Qualigen Therapeutics, Vedanta Biosciences, etc.

Market Segmentation
By Company
    Enterome
    Ferring Pharmaceuticals
    Finch Therapeutics Group
    MaaT Pharma
    Seres Therapeutics
    OpenBiome
    Qualigen Therapeutics
    Vedanta Biosciences

Segment by Type
    Transcolonoscopic Transplantation
    Nasoenteric Tube Perfusion
    Oral Capsule

Segment by Application
    Clostridium Difficile Infection (CDI)
    Inflammatory Bowel Disease (IBD)
    Irritable Bowel Syndrome (IBS)
    Metabolic Syndrome
    Neurological Diseases
    Others

Production by Region
    North America
    Europe
    Asia-Pacific
    Latin America
    Middle East & Africa

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Fecal Transplant Treatment production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Fecal Transplant Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Fecal Transplant Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fecal Transplant Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
 Table 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Transcolonoscopic Transplantation
 Table 3. Key Players of Nasoenteric Tube Perfusion
 Table 4. Key Players of Oral Capsule
 Table 5. Global Fecal Transplant Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Fecal Transplant Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 8. Global Fecal Transplant Treatment Market Share by Region (2020-2031)
 Table 9. Market Trends
 Table 10. Market Drivers
 Table 11. Market Challenges
 Table 12. Market Restraints
 Table 13. Global Fecal Transplant Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 14. Global Fecal Transplant Treatment Market Share by Players (2020-2025)
 Table 15. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2024)
 Table 16. Global Fecal Transplant Treatment Industry Ranking 2023 VS 2024
 Table 17. Global 5 Largest Players Market Share by Fecal Transplant Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 18. Global Key Players of Fecal Transplant Treatment, Headquarters and Area Served
 Table 19. Global Key Players of Fecal Transplant Treatment, Product and Application
 Table 20. Global Key Players of Fecal Transplant Treatment, Date of Enter into This Industry
 Table 21. Mergers & Acquisitions, Expansion Plans
 Table 22. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 23. Global Fecal Transplant Treatment Revenue Market Share by Type (2020-2025)
 Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 25. Global Fecal Transplant Treatment Revenue Market Share by Type (2026-2031)
 Table 26. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 27. Global Fecal Transplant Treatment Revenue Market Share by Application (2020-2025)
 Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 29. Global Fecal Transplant Treatment Revenue Market Share by Application (2026-2031)
 Table 30. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 31. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 32. North America Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 36. Europe Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 38. China Market Size by Type (2020-2031) & (US$ Million)
 Table 39. China Market Size by Application (2020-2031) & (US$ Million)
 Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 42. Asia Fecal Transplant Treatment Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 46. Middle East, Africa, and Latin America Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 48. Enterome Company Details
 Table 49. Enterome Business Overview
 Table 50. Enterome Fecal Transplant Treatment Product
 Table 51. Enterome Revenue (2020-2025) & (US$ Million)
 Table 52. Enterome Recent Development
 Table 53. Ferring Pharmaceuticals Company Details
 Table 54. Ferring Pharmaceuticals Business Overview
 Table 55. Ferring Pharmaceuticals Fecal Transplant Treatment Product
 Table 56. Ferring Pharmaceuticals Revenue (2020-2025) & (US$ Million)
 Table 57. Ferring Pharmaceuticals Recent Development
 Table 58. Finch Therapeutics Group Company Details
 Table 59. Finch Therapeutics Group Business Overview
 Table 60. Finch Therapeutics Group Fecal Transplant Treatment Product
 Table 61. Finch Therapeutics Group Revenue (2020-2025) & (US$ Million)
 Table 62. Finch Therapeutics Group Recent Development
 Table 63. MaaT Pharma Company Details
 Table 64. MaaT Pharma Business Overview
 Table 65. MaaT Pharma Fecal Transplant Treatment Product
 Table 66. MaaT Pharma Revenue (2020-2025) & (US$ Million)
 Table 67. MaaT Pharma Recent Development
 Table 68. Seres Therapeutics Company Details
 Table 69. Seres Therapeutics Business Overview
 Table 70. Seres Therapeutics Fecal Transplant Treatment Product
 Table 71. Seres Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 72. Seres Therapeutics Recent Development
 Table 73. OpenBiome Company Details
 Table 74. OpenBiome Business Overview
 Table 75. OpenBiome Fecal Transplant Treatment Product
 Table 76. OpenBiome Revenue (2020-2025) & (US$ Million)
 Table 77. OpenBiome Recent Development
 Table 78. Qualigen Therapeutics Company Details
 Table 79. Qualigen Therapeutics Business Overview
 Table 80. Qualigen Therapeutics Fecal Transplant Treatment Product
 Table 81. Qualigen Therapeutics Revenue (2020-2025) & (US$ Million)
 Table 82. Qualigen Therapeutics Recent Development
 Table 83. Vedanta Biosciences Company Details
 Table 84. Vedanta Biosciences Business Overview
 Table 85. Vedanta Biosciences Fecal Transplant Treatment Product
 Table 86. Vedanta Biosciences Revenue (2020-2025) & (US$ Million)
 Table 87. Vedanta Biosciences Recent Development
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Fecal Transplant Treatment Market Share by Type: 2024 VS 2031
 Figure 3. Transcolonoscopic Transplantation Features
 Figure 4. Nasoenteric Tube Perfusion Features
 Figure 5. Oral Capsule Features
 Figure 6. Global Fecal Transplant Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Global Fecal Transplant Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Clostridium Difficile Infection (CDI) Case Studies
 Figure 9. Inflammatory Bowel Disease (IBD) Case Studies
 Figure 10. Irritable Bowel Syndrome (IBS) Case Studies
 Figure 11. Metabolic Syndrome Case Studies
 Figure 12. Neurological Diseases Case Studies
 Figure 13. Others Case Studies
 Figure 14. Fecal Transplant Treatment Report Years Considered
 Figure 15. Global Fecal Transplant Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Fecal Transplant Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Fecal Transplant Treatment Market Share by Region: 2024 VS 2031
 Figure 18. Global Fecal Transplant Treatment Market Share by Players in 2024
 Figure 19. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Fecal Transplant Treatment Revenue in 2024
 Figure 21. North America Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Fecal Transplant Treatment Market Share by Type (2020-2031)
 Figure 23. North America Fecal Transplant Treatment Market Share by Application (2020-2031)
 Figure 24. North America Fecal Transplant Treatment Market Share by Country (2020-2031)
 Figure 25. United States Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Fecal Transplant Treatment Market Share by Type (2020-2031)
 Figure 29. Europe Fecal Transplant Treatment Market Share by Application (2020-2031)
 Figure 30. Europe Fecal Transplant Treatment Market Share by Country (2020-2031)
 Figure 31. Germany Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. China Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. China Fecal Transplant Treatment Market Share by Type (2020-2031)
 Figure 39. China Fecal Transplant Treatment Market Share by Application (2020-2031)
 Figure 40. Asia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Asia Fecal Transplant Treatment Market Share by Type (2020-2031)
 Figure 42. Asia Fecal Transplant Treatment Market Share by Application (2020-2031)
 Figure 43. Asia Fecal Transplant Treatment Market Share by Region (2020-2031)
 Figure 44. Japan Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. South Korea Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. China Taiwan Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Southeast Asia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. India Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Australia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Type (2020-2031)
 Figure 52. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Application (2020-2031)
 Figure 53. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Country (2020-2031)
 Figure 54. Brazil Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Mexico Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Turkey Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Israel Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 59. GCC Countries Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 60. Enterome Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 61. Ferring Pharmaceuticals Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 62. Finch Therapeutics Group Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 63. MaaT Pharma Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 64. Seres Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 65. OpenBiome Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 66. Qualigen Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 67. Vedanta Biosciences Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed